Introduction
During the 2009 influenza A H1N1 pandemic (pH1N1), North American indigenous populations suffered disproportionately compared to the general population, as shown by higher rates of influenza-like illness 1 , hospitalization 2, 3, 4 , intensive care unit admissions 4, 5, 6 and a four-fold increased rate of death 7 . We conducted a case-control investigation to determine risk factors for death due to 2009 H1N1 influenza A (pH1N1) in five U.S. states with large American Indian/Alaska Native (AI/AN) populations. Our objectives were to determine: 1) whether AI/AN racial status was an independent risk factor for death and, 2) the risk factors for death within the AI/AN population.
Methods
This investigation was conducted in Alaska, Arizona, New Mexico, Oklahoma and Wyoming. Case-patients (cases) were state residents who died related to infection with laboratory-confirmed influenza A from April 15, 2009 through January 31, 2010. Influenza infection was defined by a positive polymerase chain reaction (PCR) test, viral culture confirming pH1N1, a rapid influenza A test, or a direct fluorescent antibody test on a specimen collected from April 15 through December 31, 2009. We excluded cases who had no contact with a health care provider in the 14 days before death, or whose death and illness onset occurred when the person was located outside their state.
We attempted to match cases with two control-patients based on state of residence and influenza specimen date (within 14 days). Controls were state residents who had laboratoryconfirmed pH1N1 infection (confirmed by PCR or culture) from April 15 through December 31, 2009 and who were not hospitalized for influenza within 30 days after their specimen collection date. Cases and controls were identified from death certificates and notifiable disease reports. Death certificates and medical records were abstracted using a standard form. Additionally, we interviewed a case proxy, defined as an adult who lived with or cared for the case prior to their illness, or a relative or close friend who lived nearby, or a relative knowledgeable of the case. If no case proxy was interviewed, we abstracted seven of the questions from the medical record. Interviews began October 2010 and ended March 2012. Data on fatalities from influenza for the U.S. population was obtained from national surveillance.
Four of the states required reporting of positive laboratory tests for pH1N1 (PCR and culture). Oklahoma obtained laboratory data from tests done by its Public Health Laboratory. Outpatients with pH1N1 were randomly-selected and contacted for an interview. Participant's individual medical records were obtained and we abstracted demographic information, height, weight, health insurance status, medical and vaccination history, and influenza illness treatments. From interviews we obtained self-identified race, household characteristics, access to healthcare, past medical history, tobacco and alcohol habits, income and educational attainment.
Data were double entered into Paradox v 9.0 (Corel, Ottawa, Canada). Univariable tests were run in a conditional logistic regression model using the Wald chi-square statistic. Households with ≥ 1.5 persons per room were considered crowded and poverty was defined as having an annual household income < $25,000 8 . Obesity was defined as a BMI ≥30 (adults), a BMI ≥ 95 th percentile for age (2-17 year olds), or ≥ 95 th percentile of weight for age (<2 years old). Influenza-like illness (ILI) was defined by a reported fever, and either a cough or a sore throat. Age was modeled using three classes (< 18, 18-44 and ≥ 45 years). Receipt of antiviral medications was categorized into 3 levels: none, received ≤ 2 days after symptom onset, received ≥ 3 days after symptom onset.
Missing data ranged from 0% (age) to 25% (income). Missing data imputation procedures were employed, assuming data were missing at random. Data were imputed using Markov chain Monte Carlo iterations assuming a multivariate normal distribution 9,10,11 . The imputation model included variables for state of residence and specimen collection date, and all variables in the univariable analyses and case-control membership. Dichotomous variables derived from continuous variables were imputed in their continuous form; other dichotomous variables were imputed as dichotomous indicators 9, 10 . We created 20 imputed datasets for the multivariable models 12 . A single chain was used with 200 burn-in iterations and 100 iterations between datasets. Each imputed dataset was analyzed using conditional logistic regression and then estimates were combined accounting for the parameter variability estimates and the variability associated with the imputation process. Analyses were conducted in SAS using logistic and imputation procedures 13 . Multivariable models used purposeful forward selection and included variables with a univariate p-value < 0.25 14 . After determining main effects, all two-way interactions with appropriate sample sizes were evaluated for statistical significance. Variable selection was repeated on the imputed datasets using the combined Wald χ 2 statistic that incorporated the between-and within-imputation variation components 15 . Multivariable models included: the imputation model and a complete case analysis, where matched pairs or observations were entered or missing based on whether they had missing data for any given risk factor in the model.
A multivariable model restricted to AI/AN persons evaluated a subset of factors, due to sample size limitations, including demographics, healthcare access, one socio-economic variable, and all other variables that had adequate sample sizes. The variables that were used to match cases and controls were considered independent predictors in this model. Model diagnostics were run to identify influential observations or matched pairs in terms of model fit and parameter point and variance estimates. All p-values were two-sided and a value < 0.05 was considered statistically significant.
Results
A total of 257 fatalities associated with influenza A infection were reported in these states (annualized mortality: 6.6/100,000 persons/year). Of these, 145 met the case definition ( Table 1 ). The epidemic peak occurred during calendar weeks 40 -44, similar to the overall U.S. epidemic (Figure) . Thirty-two fatalities were excluded, principally because they did not see a healthcare provider prior to death (90%); 69% of excluded cases were from Arizona. Eighty fatalities from Arizona were not included in analysis because of incomplete data or because Tribal approvals were not obtained. These persons were similar to the cases included from Arizona with regard to sex, age, diagnosis date, and underlying medical conditions; however, those not included were more likely to be of AI/AN racial status than the included fatal cases (26% vs. 11%, p = 0.01).
We recruited 236 controls; 91 (63%) cases were matched to two controls and 54 were matched to one control. Proxy interviews with could not be obtained for 43 (30%) of fatal cases. Univariate risk factors for death are shown in Table 2 . Multivariable analysis identified four independent risk factors for a fatal infection (Table 3) : older age, having a pre-existing medical condition, being a smoker and receiving antivirals 3 or more days after illness onset. Using the imputed data set, a fifth independent variable was identified: a financial or transportation-related barrier to healthcare access. AI/AN race was not significantly associated with death after adding age and preexisting conditions to the models. There were no significant two-way interactions between the risk factors in the final models.
Mortality risk factors for the 70 AI/AN participants are in Table 4 . Multivariable analysis identified two independent risk factors for death: pre-existing medical conditions and obesity (Table 3) . Using the imputed data, a third independent risk factor was identified: having been a smoker.
Discussion
In this case-control investigation from U.S. states with substantial AI/AN populations, we used medical records and interviews to assess potential risk factors for pH1N1 influenza A mortality. Three of the risk factors are modifiable (smoking, delayed receipt of antiviral medications, and a barrier to accessing health care). The association of death with smoking and a barrier to healthcare access have not been previously described for influenza 16, 17 . Two other risk factors (older age and underlying medical conditions) are well recognized. AI/AN persons were overrepresented among the fatal cases (22% vs. 16% of controls, p = 0.05); however, AI/AN racial status was not an independent risk for death. The risk factors for death among the AI/AN population (pre-existing medical conditions, smoking, obesity) are similar to other North American populations 17, 18, 19 . This is the first population-based investigation to evaluate AI/AN race as a potential risk factor for influenza mortality and the first to evaluate influenza mortality risk factors among the AI/AN population.
Smoking has not been previously identified as a risk factor for influenza mortality 16 . Other studies of mortality risk during this pandemic either did not evaluate smoking 17, 18 or did not show an association when they compared fatal and hospitalized patients 20, 21 . The prevalence of smoking among controls (11% for those 7 years or older) was much lower than the adult smoking prevalence in these states, which ranges from 19.2% to 26.1% 22 . This could have led to an overestimation of the magnitude of this risk factor. Despite this potential limitation, smoking is a biologically plausible risk factor and should be investigated further.
The financial or transportation-related barriers to healthcare access may have caused patients to delay seeking care after illness-onset, resulting in more severe illness that was less amenable to treatment. Although 93% of the fatal cases had health insurance, insurance coverage differs with regard to costs paid by the patient and healthcare seeking behavior is complicated. Further investigation is needed to identify ways to reduce barriers to healthcare among high-risk individuals, with and without health insurance.
Whether AI/AN race is, by itself, a risk factor for death or is a marker for other factors has substantial implications. Finding that AI/AN racial status was a risk factor might imply an undiscovered genetic susceptibility to severe influenza. A genetic explanation offers limited prevention options and could have a chilling effect on efforts to reduce influenza mortality among AI/AN 23 . Because AI/AN race is a marker for other risk factors, we can now focus on those modifiable risks among AI/AN persons. Three risk factors from the AI/AN-specific model were common among fatal cases (obesity 61%, smoking 35%, pre-existing conditions 69%). Similar to the overall population, we observed trends among AI/AN persons for higher mortality for older age, delay in antivirals (cases 36%, controls 9%), and healthcare access barriers (cases 35%, controls 11%). Accessing healthcare is a problem for AI/AN persons with influenza 1 . Among adults in 2009, AI/AN persons had the highest frequency of influenza-like illness of any racial group (16.2% vs. 8.2% overall), yet were the least likely to seek healthcare (37.4% vs. 42.1% overall). Further efforts are indicated to improve access and healthcare seeking behavior among AI/AN persons. Environmental determinants for lower respiratory tract infections common among AI/AN populations deserve further attention. These include household crowding 24, 25 , limited access to in-home water and sanitation services 26,27,28 , and household air pollution from wood-burning stoves or secondhand tobacco smoke 29 .
The influenza mortality disparity between AI/AN persons and the general population is a challenge for influenza preparedness 30 . Prior to 2009, AI/ANs were not prioritized to receive vaccine or antiviral medications on the basis of racial status in the US. However, recommendations now include AI/AN persons as a high-risk group 31,32 . Some might consider that a risk factor-based strategy would be sufficient to identify AI/AN persons at risk for influenza complications. However, using the criteria for receipt of antiviral medications, 30% of fatal AI/AN cases would not have been considered high risk. In contrast, only 16% of influenza fatalities among whites would not have been considered high risk. AI/AN persons during 2009 also suffered disproportionately from influenza illness, hospitalizations and intensive care unit admissions. This is similar to the experience of AI/AN persons throughout the past 2 decades 33 . Thus, a risk factor-based strategy may not be comprehensive enough to address these long-standing influenza disparities. Designating AI/AN persons as high-risk can allow a more rapid delivery of vaccine, antiviral medications and education through U.S. Indian Health Service, tribal and urban Indian clinics. Thus, maintaining the high risk designation may be more likely to reduce the health disparity than a risk factor-based approach.
Influenza immunization uptake among AI/AN persons is similar to the general United States population, but should be improved 34, 35 . Efforts to reduce smoking prevalence and obesity among AI/AN persons may be beneficial in reducing influenza mortality. Smoking prevalence among AI/AN adults (31.4%) far exceeds the overall U.S. population (19.0%) 36 . Likewise, obesity among AI/AN adults (39.6% prevalence) is more common that among non-Hispanic whites (26%) 37 .
These findings may not be generalizable to the entire U.S. or to all AI/AN persons. Because controls had access to health care and telephone service, comparisons for related socioeconomic factors may have been limited by design. By modelling only three age categories our ability to detect gradations in risk within age classes is limited. Missing data was addressed through multiple imputation which improved the power but would not solve potential bias related to representativeness of the population. We may have underestimated the AI/AN persons among the fatalities, since misclassification of AI/AN decedents has been documented 38 . Since approval was not obtained from all Arizona tribes, there was systematic under-recruitment of AI/AN persons and reduced representativeness of the included cases. Glucocorticoids used as a fever-reducing agent was identified as a risk factor for influenza death in China 39 . This is not a recommended practice in the United States 40 . However, because we did not obtain the timing or dosage of corticosteroid administration and nearly 50% of the fatal cases had received steroids, this remains a potential, uncontrolled confounder.
During the 2009 pandemic, AI/AN racial status was not independently associated with death, but was a marker for other modifiable factors. Keeping AI/AN race among the highrisk conditions for influenza complications should be considered as an appropriate response to the elevated risk of morbidity and mortality in this population. Increased efforts to reduce influenza mortality are needed to address this longstanding health disparity. 
P-value
Specimen Collection Date April -September, October, November or Later 31% (10) 37% (14) 50% (16) 
